drugset / Trial / NCT00400530

Upper GI Handling of Branded vs. Generic Alendronate

NCT00400530

Phase 3 Completed 25 enrolled Merck Sharp & Dohme LLC
RandomizedCrossoverSingle-blindTreatment

Summary

To compare upper GI handling of fosamax and generic, because the main AE profile of alendronate is before systemic absorption in the esophagus; differences could be relevant to the side effect profile.

Timeline

Start
2005-12
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Alendronic Acid Small molecule

Indications